SELLAS Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. 

CEO
Angelos M. Stergiou
CEOAngelos M. Stergiou
Employees
13
Employees13
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2006
Founded2006
Employees
13
Employees13

SLS Key Statistics

Market cap
2.33B
Market cap2.33B
Price-Earnings ratio
-53.49
Price-Earnings ratio-53.49
Dividend yield
—
Dividend yield—
Average volume
6.79M
Average volume6.79M
High today
$11.67
High today$11.67
Low today
$11.08
Low today$11.08
Open price
$11.28
Open price$11.28
Volume
3.28M
Volume3.28M
52 Week high
$15.88
52 Week high$15.88
52 Week low
$1.39
52 Week low$1.39

Stock Snapshot

SELLAS Life Sciences(SLS) stock is priced at $11.58, giving the company a market capitalization of 2.33B. It carries a P/E multiple of -53.49.

During the trading session on 2026-10-23, SELLAS Life Sciences(SLS) shares reached a daily high of $11.67 and a low of $11.08. At a current price of $11.58, the stock is +4.5% higher than the low and still -0.8% under the high.

Trading activity shows a volume of 3.28M, compared to an average daily volume of 6.79M.

Over the past 52 weeks, SELLAS Life Sciences(SLS) stock has traded between a high of $15.88 and a low of $1.39.

Over the past 52 weeks, SELLAS Life Sciences(SLS) stock has traded between a high of $15.88 and a low of $1.39.

SLS News

Simply Wall St 1d
SELLAS Life Sciences Group Nears GPS Phase 3 Readout On A Pricey Valuation

SELLAS Life Sciences Group (SLS) has drawn fresh focus after confirming that 78 of 80 required events in its pivotal Phase 3 GPS trial have occurred, bringing t...

SELLAS Life Sciences Group Nears GPS Phase 3 Readout On A Pricey Valuation
Simply Wall St 4d
Why SELLAS Life Sciences Group Stock Is Up 5.1% And What's Next

SELLAS Life Sciences Group marked its 15th anniversary with CEO Angelos Stergiou highlighting the progress of late stage oncology programs and investor focus on...

Why SELLAS Life Sciences Group Stock Is Up 5.1% And What's Next

People also own

Based on the portfolios of people who own SLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.